StockMarketWire.com - Kepler Cheuvreux today reaffirms its buy investment rating on AstraZeneca PLC [LON:AZN] and cut its price target to 7700p (from 8000p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk